{"schema_version":"1","generated_at":"2026-11-12T13:55:26.050Z","data_as_of":null,"url":"https://www.findmykol.com/kol/robert-mittman","json_url":"https://www.findmykol.com/kol/robert-mittman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"robert-mittman","name":"Robert Mittman","credential":"MD","specialty":"Allergy & Immunology","specialty_raw":"Allergy & Immunology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"city":"Bayside","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1821166877","openalex":"A5112178713"},"summary":"Robert Mittman is a Rheumatology/Immunology physician. OpenAlex indexes 13 publications with 415 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":13,"cited_by_count":415,"h_index":5,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":61,"program_years":{"first":2021,"last":null},"rows_total":150,"shown":3,"withheld":147,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":1641.98,"payment_count":47,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821166877"},{"payer":"GlaxoSmithKline, LLC.","program_year":2025,"amount_usd":1346.54,"payment_count":46,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821166877"},{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":1038.7,"payment_count":33,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821166877"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1821166877","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Respiratory","share_pct":37,"classes_total":6,"classes":[{"class":"Anti-IgE","setting":"mixed","share_pct":32.3,"drugs":[{"name":"Omalizumab","share_pct":99.2},{"name":"Xolair","share_pct":0.8}],"max_beneficiaries":null},{"class":"Leukotriene Receptor Antagonist","setting":"prescribed","share_pct":2.2,"drugs":[{"name":"Montelukast Sodium","share_pct":100}],"max_beneficiaries":38}]},{"area":"Anti-infectives","share_pct":25.3,"classes_total":5,"classes":[{"class":"Glycopeptide Antibacterial","setting":"administered","share_pct":22.1,"drugs":[{"name":"Vancomycin hcl","share_pct":100}],"max_beneficiaries":43},{"class":"Penicillins with extended spectrum","setting":"prescribed","share_pct":1.5,"drugs":[{"name":"Amoxicillin-Clavulanate Potass","share_pct":100}],"max_beneficiaries":48}]},{"area":"Sensory organs","share_pct":22.3,"classes_total":2,"classes":[{"class":"Aminoglycoside Antibacterial","setting":"administered","share_pct":22.1,"drugs":[{"name":"Tobramycin sulfate","share_pct":100}],"max_beneficiaries":43},{"class":"Fluoroquinolone Antibacterial","setting":"prescribed","share_pct":0.2,"drugs":[{"name":"Ciprofloxacin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"OpenAlex author record","recent":[{"title":"Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE","year":2017,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-17-0764","status":"verified"},{"title":"Unprecedented Opportunity: Using Federal Stimulus Funds to Advance Health IT in California","year":2009,"status":"verified"},{"title":"What California Stands to Gain: the Impact of the Stimulus Package on Healthcare","year":2009,"status":"verified"},{"title":"Impact of Federal Stimulus Efforts on the Privacy and Security of Health Information in California","year":2009,"status":"verified"},{"title":"Using Clinical Information Technology in Chronic Disease Care: Expert Workshop Summary","year":2004,"status":"verified"}],"source":"works"},"contact":{"address_1":"3821 BELL BLVD","city":"Bayside","state":"NY","zip":"113612058","phone":"718-423-9300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1821166877","source":"identity"},"similar":[{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":147,"publications":8}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-01-12","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}